Panophthalmitis After Aurolab Aqueous Drainage Implant (AADI) in Refractory Glaucoma with Vogt-Koyanagi-Harada Syndrome (VKH): A Case Report

Md Iftekher Iqbal; Syed Jahangir Kabir; Bipul Kumer De Sarker

doi:10.54646/bijcroo.2023.22

PDF HTML XML EPUB

Abstract Views: 180

PDF Views/Downloads: 54

HTML Views/Downloads: 21

XML Views/Downloads: 31

EPUB Views/Downloads: 29

How to Cite

1.

Iftekher Iqbal M, Jahangir Kabir S, Kumer De Sarker B. Panophthalmitis After Aurolab Aqueous Drainage Implant (AADI) in Refractory Glaucoma with Vogt-Koyanagi-Harada Syndrome (VKH): A Case Report. BOHR International Journal of Current Research in Optometry and Ophthalmology [Internet]. 2023 Jan. 24 [cited 2024 Nov. 9];2(1):1-4. Available from: https://journals.bohrpub.com/index.php/bijcroo/article/view/113

Published: Jan 24, 2023

DOI: https://doi.org/10.54646/bijcroo.2023.22

Dimensions Citation count:

Keywords:

Panophthalmitis
Aurolab Aqueous Drainage Implant
Vogt-Koyanagi-Harada Disease
Refractory Glaucoma

Authors

Md Iftekher Iqbal

Glaucoma Department, Ispahani Islamia Eye Institute and Hospital, Sher-E-Bangla Nagar, Farmgate, Dhaka-1215, Bangladesh

Syed Jahangir Kabir

Glaucoma Department, Ispahani Islamia Eye Institute and Hospital, Sher-E-Bangla Nagar, Farmgate, Dhaka-1215, Bangladesh

Bipul Kumer De Sarker

Glaucoma Department, Ispahani Islamia Eye Institute and Hospital, Sher-E-Bangla Nagar, Farmgate, Dhaka-1215, Bangladesh

Abstract

This case of Vogt-Koyanagi-Harada (VKH) disease underwent Aurolab Aqueous Drainage Implant (AADI) for refractory glaucoma. Later, developed postoperative (2 months) panophthalmitis characterized by sudden visual loss, moderate pain, redness, and purulent discharge. Systemic, topical, and intravitreal antibiotic therapy was started immediately, and evisceration was performed.

Share This Article On Social Media

Usage Statistics